K Nambu
Overview
Explore the profile of K Nambu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nambu K, Nariai T, Terada T
Acta Neurochir Suppl
. 2004 Feb;
86:53-5.
PMID: 14753404
We developed a method to measure regional permeability of cerebral capillary vessels, extracellular fluid space volume, and vascular bed volume using multi-slice dynamic CT with iodinated contrast medium. We implemented...
2.
Iseki H, Muragaki Y, Taira T, Kawamata T, Maruyama T, Naemura K, et al.
Stereotact Funct Neurosurg
. 2002 Oct;
76(3-4):159-67.
PMID: 12378094
Information-guided stereotaxis, assisted by visualization of medical information, will become the next generation of neurosurgical systems. We performed 76 open MRI surgeries at Tokyo Women's Medical University between March 3,...
3.
Inouye K, Lee S, Nambu K, TONOMURA B
J Biochem
. 1997 Aug;
122(2):358-64.
PMID: 9378714
The activity of thermolysin in the hydrolysis of N-[3-(2-furyl)acryloyl] (FA)-dipeptide amides and N-carbobenzoxyl-L-aspartyl-L-phenylalanine methyl ester is remarkably enhanced by high concentrations (1-5 M) of neutral salts. The activation is due...
4.
Nambu K, Takehara R, Terada T
Acta Neurol Scand Suppl
. 1996 Jan;
166:28-31.
PMID: 8686437
No abstract available.
5.
Nambu K, Suzuki R, Hirakawa K
Radiology
. 1995 Apr;
195(1):53-7.
PMID: 7892495
Purpose: To improve CT number reproducibility in helical CT, a newly developed controlled-orbit helical scan mechanism was applied. The authors developed a method for volumetric measurement of cerebral blood flow...
6.
Terada T, Nambu K, Hyotani G, Miyamoto K, Tsuura M, Nakamura Y, et al.
Neuroradiology
. 1992 Jan;
34(4):290-6.
PMID: 1528436
Cerebral vascular permeability is an important consideration in treatment for intracranial tumours. We have developed a new method to measure the cerebral vascular permeability quantitatively using a conventional X-ray CT...
7.
Matsunaga Y, Miyazaki H, Nambu K, Furukawa H, Yoshida K, Hashimoto M
Arzneimittelforschung
. 1991 Jul;
41(7):747-59.
PMID: 1663354
Disposition and metabolism of [carbonyl-14C]sparfloxacin SPFX, 5-amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro- 1,4-dihydro-4-oxoquinoline-3-carboxylic acid, AT-4140; CAS 110871-86-8), a novel antimicrobial quinolone, were studied in rats mainly after oral administration at 10 mg/kg. SPFX was absorbed...
8.
Nambu K, Yoshida K, Kagemoto A, Matsumoto K, Miyazaki H, Hashimoto M, et al.
Arzneimittelforschung
. 1988 Jul;
38(7):909-18.
PMID: 3207436
Disposition and metabolism of [14C]-amezinium metilsulfate (4-amino-6-methoxy-1-phenylpyridazinium methylsulfate, Risumic) were systematically studied in rats after intravenous (5 mg/kg) or oral (20, 100 mg/kg) administration. After oral administration at 20 mg/kg,...
9.
Miyazaki H, Iida M, Matsunaga Y, Fujii T, Nambu K, Amejima H, et al.
Biotherapy
. 1988 Jan;
1(1):47-57.
PMID: 3275291
The mode of antitumor action of rHu-TNF was elucidated in BALB/c mice bearing Meth A fibrosarcoma 7 days after transplantation with respect to time course, dose-response relationships and selectivity of...
10.
Miyazaki H, Fujii T, Amejima H, Mikuriya N, Nambu K, Kagemoto A, et al.
Biotherapy
. 1988 Jan;
1(1):7-18.
PMID: 3079460
Disposition of [125I]rHu-TNF was elucidated in BALB/c mice bearing Meth A fibrosarcoma 7 days after transplantation. After i.v. administration, [125I]rHu-TNF measured by radioactivity and immunoreactivity biphasically decreased in plasma. Tumor...